Immunome
IMNM
IMNM
30 hedge funds and large institutions have $9.34M invested in Immunome in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
70% less call options, than puts
Call options by funds: $49K | Put options by funds: $163K
Holders
30
Holding in Top 10
1
Calls
$49K
Puts
$163K
Top Buyers
| 1 | +$747K | |
| 2 | +$83K | |
| 3 | +$77K | |
| 4 |
Renaissance Technologies
New York
|
+$38.9K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$27.6K |
Top Sellers
| 1 | -$1.76M | |
| 2 | -$331K | |
| 3 | -$47.5K | |
| 4 |
N
Natixis
Paris,
France
|
-$39.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.43K |